Atlas Trials

Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Clinical trial NCT06238544 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06238544
Sponsor
Chengdu Suncadia Medicine Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Paroxysmal Nocturnal Hemoglobinuria
Start date
2024-02-06
Primary completion
2027-12-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.